Both in Pharmaceuticals
SELLAS Life Sciences Group vs Zenas BioPharma
Over the past year SLS returned +450.6% and ZBIO returned −5.0%; their daily moves had a correlation of 0.10.
SLS +450.6% ZBIO −5.0%Growth of $1, one year, split-adjusted
| Metric | SLS | ZBIO |
|---|---|---|
| Price | $9.14 | $28.46 |
| Market cap | $1.85B | $1.85B |
| Today | +3.04% | +0.28% |
| 1 month | −19.4% | +5.6% |
| 6 months | +77.5% | +36.6% |
| Year to date | +142.4% | −21.6% |
| 1 year | +410.6% | −9.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −11145.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 1,854.9× |
| Net cash | $138.3M | $346.1M |
| Dividend yield | — | — |
| Volatility (60d) | 97.0% | 55.8% |
| Short % of float | 27.0% | 40.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).